Published 2016 | Version v1
Publication

Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis

Additional details

Identifiers

URL
http://hdl.handle.net/11567/871628
URN
urn:oai:iris.unige.it:11567/871628

Origin repository

Origin repository
UNIGE